Randomized Trial: Short- vs Intermediate-Term Androgen Suppression, With or Without Zoledronic Acid, in Men with Locally Advanced Prostate Cancer

Short-term androgen suppression and radiotherapy versus intermediate-term androgen suppression and radiotherapy, with or without zoledronic acid, in men with locally advanced prostate cancer (TROG 03.04 RADAR): 10-year results from a randomised, phase 3, factorial trial – The Lancet Oncology (link to abstract – $ for full-text)

Commentary: RADAR Trial: Short- vs Intermediate-Term Androgen Suppression and Zoledronic Acid in Locally Advanced Prostate Cancer – The ASCO Post (free)

New Article: 10-year results from the TROG 03.04 RADAR trial on short-term vs intermediate-term #androgen suppression & #radiotherapy +/– zoledronic acid for locally advanced #prostatecancer https://t.co/GGPqEv2UtA

— The Lancet Oncology (@TheLancetOncol) December 20, 2018